AI & Semis
Technology
Thesis
Semis' index contribution hit a quarterly high as their 10Y correlation weakened
Semis are leading the Nasdaq 100's advance again, and the leadership is concentrated enough that it's really an AI-capex-cycle question dressed up as a broad tech rally. The move is more sensitive to hyperscaler spending commentary than to the 10-year, which is a shift from where the correlation sat six months ago.
Evidence
Semis' (SMH/NVDA) contribution to the NDX advance hit a quarterly high while their 10Y correlation weakened. That combination reads as the group trading hyperscaler capex right now, with the discount rate a secondary factor. The real variable is capex extension versus digestion, not the next headline EPS print.
NDX leadership sits in two or three names, with NVDA driving a disproportionate share of the index's month. At this concentration, the AI-capex thesis and the index level have become the same trade, where owning one view means owning the other.
Semis decoupling from rates has marked peak-cycle earnings before, so reduced rate sensitivity can flag trade exhaustion instead of genuine strength. A hyperscaler guiding capex digestion breaks the read regardless of what the 10Y does next.
NVDA and SMH have moved in lockstep this window (1.00 correlation over the trailing nine sessions) while NVDA gained roughly 11.5% against SMH's 6.1% -- the basket isn't offering diversification from the single name right now, and the single name is outrunning even its own sector proxy. Owning SMH instead of NVDA outright currently isn't a different trade, it's the same trade at a smaller multiple, which sharpens rather than dilutes the concentration read above.
Semis' (SMH/NVDA) contribution to the NDX advance hit a quarterly high while their 10Y correlation weakened. That combination reads as the group trading hyperscaler capex right now, with the discount rate a secondary factor. The real variable is capex extension versus digestion, not the next headline EPS print.
Market Read
Semis now carry a quarterly-high share of the index, and the capex thesis is baked directly into the NDX level itself. The index already prices in the extension, so the risk sits stacked on one side: a digestion signal, not more spending, is what actually moves this from here.
Strongest Counter-Read
Semis decoupling from rates has coincided with peak-cycle earnings before. The same pattern showed up late in prior capex cycles, right before digestion phases, so reduced rate sensitivity here is more consistent with a tiring trade than a strengthening one.